OUTLOOK THERAPEUTICS INC
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -32.9% | +172.2% | -20.2% | -38.8% | -41.0% | +12.2% | +17.4% | -17.0% | -1.9% | +20.0% | +19.6% | |
| – | -34.2% | +183.4% | -21.1% | -39.9% | -42.9% | +13.7% | +18.5% | -17.6% | -1.3% | +21.8% | +10.8% | |
| – | -55.7% | +356.0% | -32.2% | -53.4% | -61.8% | +32.5% | +17.8% | -9.2% | +7.4% | -10.7% | +45.1% | |
| – | -55.7% | +356.0% | -32.2% | -53.4% | -61.8% | +32.5% | +17.8% | -9.2% | +7.4% | -10.7% | +45.1% | |
| – | – | – | – | – | – | – | – | -14.9% | -92.3% | +2,273.1% | -39.5% | |
| – | – | – | – | – | – | +15.9% | +14.5% | -19.1% | +3.6% | -3.3% | +50.8% | |
| – | -1.5% | +319.9% | -32.3% | -22.1% | -34.0% | -23.4% | +15.6% | -14.8% | +11.8% | -10.4% | -28.1% | |
| – | -1.6% | +17.6% | -21.3% | 0.0% | +13.4% | -48.5% | +26.9% | +45.5% | +7.1% | -20.7% | -26.2% | |
| – | +2.8% | +22.4% | -27.4% | -9.2% | +4.4% | -60.9% | +16.6% | +113.5% | +22.4% | -56.7% | +15.0% | |
| – | -47.1% | +25.4% | +27.3% | +43.5% | +53.0% | -36.3% | +32.1% | -0.7% | -28.2% | +86.3% | -50.1% | |
| – | – | – | – | – | – | – | -2.9% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +9.7% | +78.5% | -27.2% | +30.6% | +27.4% | +19.7% | -31.1% | +0.0% | +0.0% | +0.0% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.